VolitionRx Limited (NYSEAMERICAN:VNRX – Get Free Report)’s share price crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $0.00 and traded as high as $0.51. VolitionRx shares last traded at $0.49, with a volume of 169,558 shares trading hands.
VolitionRx Trading Down 2.0 %
The stock has a market cap of $30.96 million, a P/E ratio of -0.87 and a beta of 1.59.
About VolitionRx
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes.
Recommended Stories
- Five stocks we like better than VolitionRx
- Investing in Commodities: What Are They? How to Invest in Them
- Tariff Exemptions Set the Stage for a Taiwan Semiconductor Rally
- Best Stocks Under $10.00
- Mitigating Tariffs: 3 Stocks to Gain From a Weaker U.S. Dollar
- Growth Stocks: What They Are, Examples and How to Invest
- Broadcom’s Apple Relationship: AI Opportunity Meets Tariff Risk
Receive News & Ratings for VolitionRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VolitionRx and related companies with MarketBeat.com's FREE daily email newsletter.
